155 related articles for article (PubMed ID: 35333109)
1. A retrospective study of intraductal papillary neoplasia of the pancreas (IPMN) under surveillance.
Johansson K; Kaprio T; Nieminen H; Lehtimäki TE; Lantto E; Haglund C; Seppänen H
Scand J Surg; 2022; 111(1):14574969221076792. PubMed ID: 35333109
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of branch-duct intraductal papillary mucinous neoplasms with No change in first 5 Years of diagnosis.
Lee BS; Nguyen AK; Tekeste TF; Chang K; Girgis A; Adeyemo M; Hanna MS; Yao JF; Kwok KK; Giap AQ; Hunt GC; Chaya CT; Kao KT; Attam R; Ko A; Pio JR; Tovar S; Lim BS
Pancreatology; 2021 Jan; 21(1):144-154. PubMed ID: 33309223
[TBL] [Abstract][Full Text] [Related]
3. Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer: multicentre study.
Tamburrino D; de Pretis N; Pérez-Cuadrado-Robles E; Uribarri-Gonzalez L; Ateeb Z; Belfiori G; Maisonneuve P; Capurso G; Vanella G; Petrone MC; Arcidiacono PG; Vaalavuo Y; Frulloni L; Dominguez-Muñoz JE; Deprez PH; Falconi M; Del Chiaro M; Crippa S; Laukkarinen J
Br J Surg; 2022 Jun; 109(7):617-622. PubMed ID: 35511697
[TBL] [Abstract][Full Text] [Related]
4. Optimal Surveillance Interval of Branch Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas.
Han Y; Kwon W; Lee M; Jung HS; Yun WG; Cho YJ; Chae YS; Fernández-Del Castillo C; Marchegiani G; Salvia R; Goh BKP; Lee WJ; Jang JY
JAMA Surg; 2024 Apr; 159(4):389-396. PubMed ID: 38231494
[TBL] [Abstract][Full Text] [Related]
5. Long-term surveillance of branch-duct intraductal papillary mucinous neoplasms without worrisome or high-risk features.
Lattimore CM; Kane WJ; Subbarao S; Venitti C; Cramer CL; Turkheimer LM; Bauer TW; Turrentine FE; Zaydfudim VM
J Surg Oncol; 2023 Dec; 128(7):1087-1094. PubMed ID: 37530526
[TBL] [Abstract][Full Text] [Related]
6. Cyst location and presence of high grade dysplasia or invasive cancer in intraductal papillary mucinous neoplasms of the pancreas: a seven institution study from the central pancreas consortium.
Kerlakian S; Dhar VK; Abbott DE; Kooby DA; Merchant NB; Kim HJ; Martin RC; Scoggins CR; Bentrem DJ; Weber SM; Maithel SK; Ahmad SA; Patel SH
HPB (Oxford); 2019 Apr; 21(4):482-488. PubMed ID: 30361110
[TBL] [Abstract][Full Text] [Related]
7. Association of high-risk stigmata and worrisome features with advanced neoplasia in intraductal papillary mucinous neoplasms (IPMN): A systematic review.
Ohno E; Balduzzi A; Hijioka S; De Pastena M; Marchegiani G; Kato H; Takenaka M; Haba S; Salvia R
Pancreatology; 2024 Feb; 24(1):48-61. PubMed ID: 38161091
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines].
Li B; Guo SW; Shi XH; Shen S; Zhang GX; Gao SZ; Pan YQ; Xu XF; Jin G
Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):359-365. PubMed ID: 33915626
[No Abstract] [Full Text] [Related]
9. Pancreatic fat content may increase the risk of imaging progression in low-risk branch duct intraductal papillary mucinous neoplasm.
Kashiwagi K; Minami K; Seino T; Hirata K; Iwasaki E; Inoue N; Iwao Y; Kanai T
J Dig Dis; 2019 Oct; 20(10):557-562. PubMed ID: 31322828
[TBL] [Abstract][Full Text] [Related]
10. Number of Worrisome Features and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasm.
Zelga P; Hernandez-Barco YG; Qadan M; Ferrone CR; Kambadakone A; Horick N; Jah A; Warshaw AL; Lillemoe KD; Balakrishnan A; Fernández-Del Castillo C
J Am Coll Surg; 2022 Jun; 234(6):1021-1030. PubMed ID: 35703792
[TBL] [Abstract][Full Text] [Related]
11. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas.
Ohtsuka T; Fernandez-Del Castillo C; Furukawa T; Hijioka S; Jang JY; Lennon AM; Miyasaka Y; Ohno E; Salvia R; Wolfgang CL; Wood LD
Pancreatology; 2024 Mar; 24(2):255-270. PubMed ID: 38182527
[TBL] [Abstract][Full Text] [Related]
12. Progression vs Cyst Stability of Branch-Duct Intraductal Papillary Mucinous Neoplasms After Observation and Surgery.
Marchegiani G; Pollini T; Andrianello S; Tomasoni G; Biancotto M; Javed AA; Kinny-Köster B; Amini N; Han Y; Kim H; Kwon W; Kim M; Perri G; He J; Bassi C; Goh BK; Katz MH; Jang JY; Wolfgang C; Salvia R
JAMA Surg; 2021 Jul; 156(7):654-661. PubMed ID: 34009303
[TBL] [Abstract][Full Text] [Related]
13. "Trivial" Cysts Redefine the Risk of Cancer in Presumed Branch-Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Potential Target for Follow-Up Discontinuation?
Marchegiani G; Andrianello S; Pollini T; Caravati A; Biancotto M; Secchettin E; Bonamini D; Malleo G; Bassi C; Salvia R
Am J Gastroenterol; 2019 Oct; 114(10):1678-1684. PubMed ID: 31449158
[TBL] [Abstract][Full Text] [Related]
14. Systematic review on surveillance for non-resected branch-duct intraductal papillary mucinous neoplasms of the pancreas.
Kazmi SZ; Jung HS; Han Y; Yun WG; Cho YJ; Lee M; Kwon W; Castillo CF; Del Chiaro M; Marchegiani G; Goh BKP; Hijioka S; Majumder S; Nakai Y; Shin A; Jang JY
Pancreatology; 2024 May; 24(3):463-488. PubMed ID: 38480047
[TBL] [Abstract][Full Text] [Related]
15. Higher Growth Rate of Branch Duct Intraductal Papillary Mucinous Neoplasms Associates With Worrisome Features.
Kolb JM; Argiriadi P; Lee K; Liu X; Bagiella E; Gupta S; Lucas AL; Kim MK; Kumta NA; Nagula S; Sarpel U; DiMaio CJ
Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1481-1487. PubMed ID: 29535058
[TBL] [Abstract][Full Text] [Related]
16. Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation.
Marchegiani G; Pollini T; Burelli A; Han Y; Jung HS; Kwon W; Rocha Castellanos DM; Crippa S; Belfiori G; Arcidiacono PG; Capurso G; Apadula L; Zaccari P; Noia JL; Gorris M; Busch O; Ponweera A; Mann K; Demir IE; Phillip V; Ahmad N; Hackert T; Heckler M; Lennon AM; Afghani E; Vallicella D; Dall'Olio T; Nepi A; Vollmer CM; Friess H; Ghaneh P; Besselink M; Falconi M; Bassi C; Goh BK; Jang JY; Fernández-Del Castillo C; Salvia R
Gastroenterology; 2023 Oct; 165(4):1016-1024.e5. PubMed ID: 37406887
[TBL] [Abstract][Full Text] [Related]
17. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
[TBL] [Abstract][Full Text] [Related]
18. Side-branch intraductal papillary mucinous neoplasms of the pancreas: outcome of MR imaging surveillance over a 10 years follow-up.
Boraschi P; Tarantini G; Donati F; Scalise P; Cervelli R; Caramella D
Eur J Radiol Open; 2020; 7():100250. PubMed ID: 32884981
[TBL] [Abstract][Full Text] [Related]
19. Anatomical pancreatic variants in intraductal papillary mucinous neoplasm patients: a cross-sectional study.
Johansson K; Mustonen H; Seppänen H; Lehtimäki TE
BMC Gastroenterol; 2022 Aug; 22(1):394. PubMed ID: 35989322
[TBL] [Abstract][Full Text] [Related]
20. The safety and benefit of pancreatic juice cytology under ERCP in IPMN patients.
Yoshioka T; Shigekawa M; Yamai T; Suda T; Kegasawa T; Iwahashi K; Ikezawa K; Sakamori R; Yakushijin T; Hiramatsu N; Tatsumi T; Takehara T
Pancreatology; 2016; 16(6):1020-1027. PubMed ID: 27567445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
